Business · 10/02/2015Updated: 10/17/2026 · 1 min read
FDA Announces Guidance for Developing Drugs to Treat Complicated Intra-Abdominal Infections
The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop effective treatments for complicated intra-abdominal infections, a serious condition that requires prompt medical attention.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →